The heart of the matter: balancing potential cardiovascular risks with known benefits of gender-affirming testosterone

Fertil Steril. 2021 Feb;115(2):334-335. doi: 10.1016/j.fertnstert.2020.11.032. Epub 2021 Jan 6.

Authors

Daphna Stroumsa¹, Amanda R Schwartz², Molly B Moravek²

Affiliations

¹ Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan; Institute for Healthcare Policy & Innovation, University of Michigan, Ann Arbor, Michigan.
² Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.

PMID: 33358018
DOI: 10.1016/j.fertnstert.2020.11.032

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Gender Identity
Heart Disease Risk Factors
Humans
Risk Factors
Testosterone
Transgender Persons*

Substances

Testosterone